Table 1.
Mitosis Transition and Observation Times after Injection with KCBP-Ab and Preimmune Serum
| Transition | Injections with KCBP-Aba |
Injections with Preimmune Seruma |
|---|---|---|
| Time to nuclear envelope breakdown |
7.5 (2–10) (n = 8)b |
33 (20–172) (n = 8)b |
| Metaphase | 88.3 (22.5–1377) (n = 8)b63 (25–120.5) (n = 19)c |
32 (15–50) (n = 4)c |
| Anaphase | 25.5 (20–30) (n = 9)d |
26.3 (12.5–32.5) (n = 8)d |
| Telophase | 45 (30.5–60.5) (n = 22)e |
31 (25–38.5) (n = 16)e |
a
Median transition or observation times and 95% confidence limits in minutes in parentheses.
b
Cells injected during late prophase.
c
Cells injected during late prophase or prometaphase.
d
Cells injected before the onset of anaphase and followed to telophase.
e
Cells injected before or during telophase and observed in telophase for at least 10 min.